These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403 [TBL] [Abstract][Full Text] [Related]
43. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829 [TBL] [Abstract][Full Text] [Related]
44. Gynecologic brachytherapy I: Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix. Nori D; Dasari N; Allbright RM Semin Radiat Oncol; 2002 Jan; 12(1):40-52. PubMed ID: 11813150 [TBL] [Abstract][Full Text] [Related]
45. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Layland MK; Sessions DG; Lenox J Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872 [TBL] [Abstract][Full Text] [Related]
46. Update on the management of ovarian cancer. Ozols RF Cancer J; 2002; 8 Suppl 1():S22-30. PubMed ID: 12075699 [TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of the Stockholm randomized trials of postoperative radiation therapy versus adjuvant chemotherapy among 'high risk' pre- and postmenopausal breast cancer patients. Rutqvist LE; Johansson H Acta Oncol; 2006; 45(5):517-27. PubMed ID: 16864164 [TBL] [Abstract][Full Text] [Related]
48. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital. Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998 [TBL] [Abstract][Full Text] [Related]
49. The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience. Ayhan A; Gultekin M; Taskiran C; Aksan G; Celik NY; Dursun P; Salman MC; Yuce K; Kucukali T Am J Obstet Gynecol; 2006 Jan; 194(1):49-56. PubMed ID: 16389009 [TBL] [Abstract][Full Text] [Related]
51. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns. Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030 [TBL] [Abstract][Full Text] [Related]
52. [Radiotherapy of ovarian carcinoma]. Ladner HA Onkologie; 1984 May; 7 Suppl 2():36-9. PubMed ID: 6431350 [TBL] [Abstract][Full Text] [Related]
53. Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study. Oehler-Jänne C; Taverna C; Stanek N; Negretti L; Lütolf UM; Ciernik IF Hematol Oncol; 2008 Jun; 26(2):82-90. PubMed ID: 18085574 [TBL] [Abstract][Full Text] [Related]
54. Surgical management of epithelial ovarian cancer: a review of the literature. Dupont NC; Berman ML Minerva Ginecol; 2004 Dec; 56(6):547-56. PubMed ID: 15729207 [TBL] [Abstract][Full Text] [Related]
55. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). Weiser EB; Burke TW; Heller PB; Woodward J; Hoskins WJ; Park RC Gynecol Oncol; 1988 Jun; 30(2):201-8. PubMed ID: 3371745 [TBL] [Abstract][Full Text] [Related]